BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Butamax™ Advanced Biofuels LLC. Release: Court Orders Restraint on Gevo, Inc. Activity Pending Preliminary Injunction Decision


6/13/2012 11:13:10 AM

WILMINGTON, Del., June 13, 2012 -- Butamax™ Advanced Biofuels, LLC notes the U.S. Federal District Court in the District of Delaware order limiting Gevo’s commercial activities, effective immediately. The order specifies:

It is ordered that, until further order of the court, defendant Gevo, Inc., ... and those persons in active concert or participation with them who receive notice of the instant order by personal service or otherwise, shall not deliver, provide, distribute, ship, release, or transfer in any way bio-based isobutanol produced at Gevo's Luverne facility from recombinant yeast microorganisms to any third party for any use or purpose, except that it may sell its bio-based isobutanol produced at the Luverne facility to Sasol for chemical applications and the U.S. Air Force for jet fuel testing applications.

“This order provides protection for markets of key interest to Butamax,” said Paul Beckwith, Butamax CEO. “We are pleased the court took this urgent action and look forward to the Judge’s full preliminary injunction opinion.”

In 2003, BP and DuPont identified biobutanol as an ideal product to develop as an advanced biofuel. Research began in 2004 with the first patents being filed in 2005. Since that time, Butamax has built a comprehensive patent portfolio for the most cost-competitive biobutanol production technology.

About Butamax

Butamax™ Advanced Biofuels, LLC, a joint venture between BP and DuPont, was formed to develop and commercialize biobutanol as a next generation renewable biofuel for the transport market. The company benefits from the synergy of DuPont’s proven industrial biotechnology experience and BP’s global fuels market knowledge. Butamax’s proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to pump. For more information, visit www.butamax.com.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->